Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...

PSI Advisors LLC lifted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.4% during the third quarter, ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...

Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Novartis (NVS) and Eli Lilly (LLY). But which of these two stocks is more attractive to value ...

Eli Lilly (LLY) said a study of its drug Ebglyss showed it was able to improve skin and itch in patients with atopic ...

Citi raised the firm’s price target on Eli Lilly (LLY) to $1,250 from $1,060 and keeps a Buy rating on the shares following a transfer of ...

New results show Eli Lilly’s Ebglyss improved skin and itch among patients with moderate-to-severe atopic dermatitis who were previously treated with dupilumab. These results fr ...

Lilium’s stock nosedives over 55% as two key subsidiaries face insolvency. The aerospace startup struggles to secure state ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Non-Cum. Perp. Pfd. Series K)-0.44% U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L)-0.90% U.S. Bancorp Dep. Pfd ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...